FDA
approval
· 2023-08-07
FDA Approved: MESALAMINE — Supplemental Application (Actavis Pharma, Inc.)
Summary
FDA approved a supplemental application for Mesalamine (Actavis Pharma, Inc.), allowing continued marketing of Mesalamine products.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MESALAMINE (MESALAMINE)